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In the past years, the number of anew diagnosed patients
with head and neck squamous cell carcinoma (HNSCC) is
still growing. Generally, HNSCC proliferates fast, is locally
aggressive and has a high tendency to metastasize to
cervical lymph nodes. Head and neck cancer is associated
with gene-environment interaction. Several genetic altera-
tions have been reported to contribute to the development
of HNSCC, while cigarette smoking, alcohol drinking,
chronic exposure to certain industrial agents and infection
with specific subtypes of human papillomaviruses (HPV)
are considered to be important risk factors, too.
Primary HNSCC tumors and matching surgical margin
samples were collected following surgical resection from
56 patients in the Clinic of Oncological and Reconstruc-
tive Surgery, Maria Sklodowska-Curie Memorial Cancer
Center and Institute of Oncology, Gliwice. Their medical
records provided necessary medical and demographic data
including patient’s age, gender, tumor grade and stage,
regional lymph nodes, cigarette smoking and alcohol
drinking. The Ethics Committee of Maria Sklodowska-
Curie Memorial Cancer Center and Institute of Oncology
in Gliwice approved the study protocol (No KB/493-15/08
and KB/430-47/13). Average age of the patients was 56.05
(range: 29-77 years, median 58.5 years). The study
included 37 males and 19 females. 80% of patients were
smokers, 73% of them reported alcohol consumption, and
64% were both smoking and alcohol drinking. Obtained
paired non-malignant tissues were situated over 10 mm
from the tumor lesion margins and were histologically
confirmed to be cancer-free. The aim of the study was to
analyze the significance of p16, APC, MGMT, TIMP3,
SFRP1, SFRP2, CDH1, RASSF1, RORA, DAPK1 genes
expression in tumors and matching surgical margin sam-
ples. Total RNA was extracted with RNeasy Mini Kit
(Qiagen, Germany) from frozen tissue samples. Isolated
RNA; after being verified for integrity, quantity and purity;
was used for cDNA synthesis (High Capacity cDNA
Reverse Transcription Kit with RNase Inhibitor; Applied
Biosystems, USA). Gene expression levels for the above
mentioned genes were analyzed by quantitative reverse
transcription (qRT)-PCR in tumors and matching surgical
margin samples. Reaction was performed using specific
TaqMan Gene Expression Assays and TaqMan Gene
Expression Master Mix in a 7300 Real Time PCR System
(Applied Biosystems, USA). The glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) gene was used as an
internal control. Relative expression levels were calculated
according to the 2-ΔΔCT formula.
Two-sample parametrical Student’s t-test for indepen-
dent samples with equal/unequal variances showed statis-
tically significant lower expression of SFRP1 in tumor
compared to margin samples (0.30 vs 0.62, p < 0.01). One-
way analysis of variance indicated a significant main effect
of the grading stage (p < 0.05). NIR post-hoc test showed,
that grade G3 patients have significantly higher values of
DAPK gene expression than the G1 group (p < 0.05), as
well as G2 (p < 0.01). No association was found between
the genes expression and clinical parameters, except
MGMT, which low expression was associated with smok-
ing (0.87 vs 1.34, p = 0.065) and DAPK1, which low
expression was associated with alcohol consumption (0.85
vs 1.97, p = 0.074).
It has been known that the survivors of head and neck
cancer presented increased morbidity and mortality and
second primary tumors are the main reason of mortality
in this group of patients. Second primary tumors or local
recurrence are thought to be the consequences of “field
cancerization” and could be the results of exposure to
1Chair and Department of Medical and Molecular Biology, School of
Medicine with the Division of Dentistry, Medical University of Silesia in
Katowice, Zabrze, Poland
Full list of author information is available at the end of the article
Strzelczyk et al. Hereditary Cancer in Clinical Practice 2015, 13(Suppl 2):A13
http://www.hccpjournal.com/content/13/S2/A13
© 2015 Strzelczyk et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
carcinogens, frequently involving the development of mul-
tiple premalignant and malignant lesions. The initial step
of field effect is associated with various molecular lesions,
e.g. gene expression.
In conclusion, an important implication is that field
often remains after surgery and the remaining peripheral
tissue (surgical margin) poses an increased risk of develop-
ing cancer. Diagnosis and treatment of cancers ought not
to concentrate only on the tumor itself, but also on the
cancer field effect.
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